| Q33282777 | A -243A-->G polymorphism upstream of the gene encoding GAD65 associates with lower levels of body mass index and glycaemia in a population-based sample of 5857 middle-aged White subjects. |
| Q52545232 | A neural gene from Drosophila melanogaster with homology to vertebrate and invertebrate glutamate decarboxylases. |
| Q53357215 | A new solid-phase radioimmunoassay to detect anti-GAD65 autoantibodies. |
| Q73081435 | A novel high-throughput method for accurate, rapid, and economical measurement of multiple type 1 diabetes autoantibodies |
| Q61861656 | A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM |
| Q41982714 | A signal located within amino acids 1-27 of GAD65 is required for its targeting to the Golgi complex region |
| Q47815857 | A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS). |
| Q48144733 | Absence of autoantibodies against glutamate decarboxylase (GAD) in the non-obese diabetic (NOD) mouse and low expression of the enzyme in mouse islets |
| Q50918709 | Age governs gender-dependent islet cell autoreactivity and predicts the clinical course in childhood IDDM. |
| Q74229022 | Age of onset, not type of onset, affects the positivity and evanescence of IA-2 antibody |
| Q22253174 | Alternative splicing of GAD67 results in the synthesis of a third form of glutamic-acid decarboxylase in human islets and other non-neural tissues |
| Q36853549 | An islet-cell protein tyrosine phosphatase is a likely precursor to the 37-kDa autoantigen in type 1 diabetes: human and macaque sequences, tissue distribution, unique and shared epitopes, and predictive autoantibodies |
| Q50056608 | Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. |
| Q70731822 | Assignment of the rat genes coding for dopa decarboxylase (DDC) and glutamic acid decarboxylases (GAD1 and GAD2) |
| Q71788167 | Association between Antibodies to the MR 67,000 Isoform of Glutamate Decarboxylase (GAD) and Type 1 (Insulin-Dependent) Diabetes Mellitus with Coexisting Autoimmune Polyendocrine Syndrome Type II |
| Q36954438 | Association of the -243A>G, +61450C>A Polymorphisms of the Glutamate Decarboxylase 2 (GAD2) Gene with Obesity and Insulin Level in North Indian Population |
| Q48303867 | Autoantigenic reactivity of diabetes sera with a hybrid glutamic acid decarboxylase GAD67-65 molecule GAD67(1-101)/GAD65(96-585). |
| Q40575830 | Autoantigens in type 1 diabetes mellitus |
| Q28363451 | Autoimmune type 1 diabetes: resolved and unresolved issues |
| Q36202374 | Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase |
| Q48499309 | Binding of antibodies in sera from Type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme |
| Q50972009 | Calretinin inputs are confined to motoneurons for upward eye movements in monkey. |
| Q34159440 | Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes |
| Q57148226 | Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals |
| Q36695291 | Characterization of a linear epitope within the human pancreatic 64‐kDa glutamic acid decarboxylase and its autoimmune recognition by sera from insulin‐dependent diabetes mellitus patients |
| Q41005356 | Characterization of self-glutamic acid decarboxylase 65-reactive CD4+ T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus |
| Q40416734 | Circulating Zonulin Correlates with Density of Enteroviruses and Tolerogenic Dendritic Cells in the Small Bowel Mucosa of Celiac Disease Patients |
| Q37297817 | Cloning and characterization of myr 6, an unconventional myosin of the dilute/myosin-V family |
| Q45803169 | Comparative effectiveness of antinociceptive gene therapies in animal models of diabetic neuropathic pain |
| Q44886848 | Complexity of human immune response profiles for CD4+ T cell epitopes from the diabetes autoantigen GAD65. |
| Q45057620 | Conformation-dependent GAD65 autoantibodies in diabetes |
| Q37299778 | Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study. |
| Q33899197 | Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression |
| Q34111857 | Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase |
| Q38353381 | Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. |
| Q48391409 | Differential effect of fasting on hypothalamic expression of genes encoding neuropeptide Y, galanin, and glutamic acid decarboxylase |
| Q59649758 | Enzymatic and structural aspects on glutamate decarboxylase |
| Q78849136 | Expression of endocrine autoantibodies in chronic hepatitis C, before and after interferon-alpha therapy |
| Q61995630 | Expression of glutamic acid decarboxylase (GAD) in the α, β and δ cells of normal and diabetic pancreas: implications for the pathogenesis of type I diabetes |
| Q41079519 | Expression of glutamic acid decarboxylase during human neuronal differentiation: studies using the NTera-2 culture system |
| Q40575836 | GAD, diabetes, and Stiff-Man syndrome: some progress and more questions |
| Q30430711 | GAD65 antibodies, chronic psychosis, and type 2 diabetes mellitus |
| Q36137876 | GAD65 autoantibodies and its role as biomarker of Type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA). |
| Q37358994 | GAD65 autoimmunity-clinical studies. |
| Q42507827 | GAD65-mediated glutamate decarboxylation reduces glucose-stimulated insulin secretion in pancreatic beta cells. |
| Q36505520 | Genes in the GABA Pathway Increase in the Lateral Thalamus of Sprague-Dawley Rats During the Proestrus/Estrus Phase |
| Q33946742 | Genetic association analysis of behavioral inhibition using candidate loci from mouse models |
| Q36361272 | Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes |
| Q37255494 | Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes |
| Q44879677 | HLA class II is associated with the frequency of glutamic acid decarboxylase M(r) 65,000 autoantibodies in Japanese patients with insulin-dependent diabetes mellitus |
| Q33848973 | HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later |
| Q36777541 | HSV vector-mediated GAD67 suppresses neuropathic pain induced by perineural HIV gp120 in rats through inhibition of ROS and Wnt5a |
| Q35235094 | High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations |
| Q70567569 | Human autoantibodies react with glutamic acid decarboxylase antigen in human and rat but not in mouse pancreatic islets |
| Q36330292 | Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes |
| Q28288007 | ICA69 is expressed equally in the human endocrine and exocrine pancreas |
| Q41994256 | Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome |
| Q35634978 | Immune intervention yes, but for what reason, for whom, when and how? |
| Q28087365 | Immunogenetics of type 1 diabetes mellitus |
| Q44435975 | Improved in planta expression of the human islet autoantigen glutamic acid decarboxylase (GAD65). |
| Q42487438 | Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies |
| Q48337407 | Intra-accumbens infusions of antisense oligodeoxynucleotides to one isoform of glutamic acid decarboxylase mRNA, GAD65, but not to GAD67 mRNA, impairs sustained attention performance in the rat. |
| Q72429393 | Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes |
| Q47706880 | Inverse relationship between GAD65 antibody levels and severe retinopathy in younger type 1 diabetic patients |
| Q40569816 | Involvement of the proteasome in IL-1beta induced suppression of islets of Langerhans in the rat. |
| Q46115645 | Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies |
| Q35824175 | Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes |
| Q38300551 | Isolation by anion-exchange of immunologically and enzymatically active human islet glutamic acid decarboxylase 65 overexpressed in Sf9 insect cells |
| Q43830332 | Lack of association of glutamate decarboxylase 2 gene polymorphisms with severe obesity in utah |
| Q36533216 | Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain |
| Q48393344 | Molecular biology of IDDM. |
| Q78059978 | NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice |
| Q39774757 | Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. |
| Q30808583 | Nucleotide sequence and chromosomal assignment of a cDNA encoding the large isoform of human glutamate decarboxylase |
| Q47711606 | Peptide specificity of high-titer anti-glutamic acid decarboxylase (GAD)65 autoantibodies |
| Q33907374 | Plant aromatic L-amino acid decarboxylases: evolution, biochemistry, regulation, and metabolic engineering applications |
| Q36117948 | Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention |
| Q24307746 | Preparation of a rat brain histidine decarboxylase (HDC) cDNA probe by PCR and assignment of the human HDC gene to chromosome 15 |
| Q43924655 | Preservation of enzyme activity and antigenicity after mutagenesis of the membrane anchoring domain of GAD65. |
| Q33902290 | Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus |
| Q36532404 | Primary structure and cellular localization of chicken brain myosin-V (p190), an unconventional myosin with calmodulin light chains |
| Q41131246 | Quantitative analysis of islet glutamic acid decarboxylase p64 autoantibodies in insulin-dependent diabetes mellitus |
| Q24617932 | Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type |
| Q34051132 | Secretagogin is a Ca2+-binding protein identifying prospective extended amygdala neurons in the developing mammalian telencephalon |
| Q40473381 | Self and non-self antigen in diabetic autoimmunity: Molecules and mechanisms |
| Q54588538 | Stabilization of recombinantly expressed proteins. |
| Q57449587 | T Cell Proliferative Responses to Glutamic Acid Decarboxylase-65 in IDDM are Negatively Associated with HLA DR3/4 |
| Q42724811 | TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes |
| Q40934733 | The TATA-less rat GAD65 promoter can be activated by Sp1 through non-consensus elements |
| Q73486424 | Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance |
| Q24307858 | Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene |
| Q35934762 | Type 1 diabetes as a model for prediction and diagnosis |
| Q35004343 | Vaccination against type 1 diabetes |